GlaxoSmithKline

$38.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.21 (+0.55%) As of 1:31 PM EDT today
+$0.21 (+0.55%) Today

Why Robinhood?

You can buy or sell GSK and other stocks, options, ETFs, and crypto commission-free!

About GSK

GlaxoSmithKline plc, also called GlaxoSmithKline, is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). Read More The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Employees
Headquarters
Middlesex, Greater London
Founded
1999
Market Cap
94.96B
Price-Earnings Ratio
15.50
Dividend Yield
5.41
Average Volume
6.02M
High Today
$38.40
Low Today
$37.61
Open Price
$38.40
Volume
2.75M
52 Week High
$48.25
52 Week Low
$31.43

Collections

GSK News

Reuters22h

GSK to partner with Vir for potential COVID-19 treatments, invest $250 million

FILE PHOTO: The GlaxoSmithKline (GSK) logo on top of GSK Asia House is seen through vertical louvres in Singapore, March 21, 2018. Picture taken March 21, 2018.
122
MarketWatchApr 6

Vir Biotechnology shares surge on news Glaxo taking $250 million stake

U.K. pharmaceutical GlaxoSmithKline GSK, -1.48% GSK, +0.34% said it's making an equity investment in Vir Biotechnology VIR, -0.88% as part of a collaboration to
427
Financial TimesApr 6

GSK buys $250m biotech stake in hunt for Covid-19 treatment

GlaxoSmithKline is investing $250m in San Francisco-based start-up Vir Biotechnology to develop antibodies that could be used to treat coronavirus. The UK-based
4

GSK Earnings

$0.00
$0.29
$0.59
$0.88
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
per share
Actual
Available Apr 29

People Also Bought

You May Also Like

More GSK News

ReutersApr 3

BRIEF-GSK Says To Collaborate With Xiamen Innovax Biotech To Evaluate Coronavirus Vaccine Candidate

April 3 (Reuters) - GlaxoSmithKline Plc: * GSK SAYS TO COLLABORATE WITH XIAMEN INNOVAX BIOTECH TO EVALUATE RECOMBINANT PROTEIN-BASED CORONAVIRUS VACCINE CANDID
30
BenzingaApr 3

Outlook on the Indian Breakfast and Cereal Industry to 2025 - Featuring Bagrrys India, Marico & GlaxoSmithKline Among Others

Dublin, April 03, 2020 (GLOBE NEWSWIRE) -- The "India Breakfast and Cereal Market by Value, by Type, by Taste, by Company, by Region, by Tier, by City, Overview
11
ReutersApr 1

GSK can make records about lawyer-funded Zofran study public: judge

GlaxoSmithKline Plc on Wednesday won the ability to make public records it says undermine a published study funded by plaintiffs lawyers that found a link betwe
137
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.